Characteristics/NNS
in/IN
Molecular/JJ
Vibrational/JJ
Frequency/NN
Patterns/NN
between/IN
Agonists/NNS
and/CC
Antagonists/NNS
of/IN
Histamine/NN
Receptors/NNS
./.
====================
To/TO
learn/VB
the/DT
differences/NNS
between/IN
the/DT
structure-activity/NN
relationship/NN
and/CC
molecular/JJ
vibration-activity/NN
relationship/NN
in/IN
the/DT
ligand-receptor/NN
interaction/NN
of/IN
the/DT
histamine/NN
receptor/NN
,/,
47/CD
ligands/NNS
of/IN
the/DT
histamine/NN
receptor/NN
were/VBD
analyzed/VBN
by/IN
structural/JJ
similarity/NN
and/CC
molecular/JJ
vibrational/JJ
frequency/NN
patterns/NNS
./.
====================
The/DT
radial/JJ
tree/CD
that/DT
was/VBD
produced/VBN
by/IN
clustering/NN
analysis/NN
of/IN
molecular/JJ
vibrational/JJ
frequency/NN
patterns/NNS
shows/VBZ
its/PRP$
potential/JJ
for/IN
the/DT
functional/JJ
classification/NN
of/IN
histamine/NN
receptor/NN
ligands/NNS
./.
====================
G/NN
protein-coupled/JJ
receptors/NNS
(/(
GPCRs/NNS
)/)
are/VBP
regarded/VBN
to/TO
take/VB
up/IN
more/RBR
than/IN
one-fourth/DT
of/IN
marketed/JJ
human/JJ
medicines/NNS
[/(
1/CD
,/,
2/CD
]/)
./.
====================
Drugs/NNS
targeting/VBG
GPCRs/NNS
account/VBP
for/IN
the/DT
majority/NN
of/IN
the/DT
best-selling/VBG
drugs/NNS
and/CC
about/IN
40/CD
%/NN
of/IN
all/DT
prescription/NN
pharmaceuticals/NNS
in/IN
the/DT
marketplace/NN
[/(
3/CD
]/)
./.
====================
Histamine/NN
receptors/NNS
belong/IN
to/TO
one/CD
family/NN
of/IN
rhodopsin-like/JJ
class/NN
A/DT
GPCRs/NNS
,/,
and/CC
four/CD
subtypes/NNS
are/VBP
named/VBN
in/IN
chronological/JJ
order/NN
as/IN
H1/NN
,/,
H2/NN
,/,
H3/NN
,/,
and/CC
H4/NN
./.
====================
Histamine/NN
exerts/VBZ
its/PRP$
effects/NNS
through/IN
the/DT
activation/NN
of/IN
these/DT
four/CD
histamine/NN
receptors/NNS
./.
====================
Each/DT
type/NN
of/IN
histamine/NN
receptor/NN
reacts/NNS
to/TO
subtype-specific/JJ
ligands/NNS
into/IN
an/DT
active/JJ
or/CC
inactive/JJ
form/NN
./.
====================
GPCRs/NNS
are/VBP
integral/JJ
membrane/NN
proteins/NNS
that/WDT
consist/VBP
of/IN
7/CD
transmembrane/JJ
segments/NNS
connected/VBN
by/IN
3/CD
intracellular/JJ
and/CC
3/CD
extracellular/JJ
loops/NNS
of/IN
variable/JJ
length/NN
./.
====================
The/DT
crystal/JJ
structures/NNS
of/IN
GPCRs/NNS
with/IN
their/PRP$
binding/NN
ligands/NNS
have/VBP
revealed/VBN
the/DT
features/NNS
of/IN
the/DT
ligand/NN
binding/NN
pockets/NNS
and/CC
extracellular/JJ
loops/NNS
[/(
4-6/CD
]/)
./.
====================
A/DT
ligand/NN
of/IN
GPCR/NN
activates/VBZ
the/DT
receptor/NN
by/IN
changing/VBG
the/DT
receptor/NN
structure/NN
to/TO
the/DT
active/JJ
form/NN
./.
====================
The/DT
biogenic/JJ
amine/NN
histamine/NN
[/(
2-/CD
(/(
1H-imidazol-5-yl/JJ
)/)
ethanamine/NN
]/)
(/(
Fig/NN
./.
====================
1/CD
)/)
is/VBZ
produced/VBN
by/IN
decarboxylation/NN
of/IN
L-histidine/NN
and/CC
acts/VBZ
as/IN
a/DT
chemical/JJ
mediator/NN
and/CC
neurotransmitter/NN
in/IN
central/JJ
and/CC
peripheral/JJ
tissues/NNS
./.
====================
It/PRP
acts/VBZ
as/IN
an/DT
important/JJ
pharmacological/JJ
modulator/NN
involved/VBN
in/IN
the/DT
processes/NNS
of/IN
allergy/NN
,/,
inflammation/NN
,/,
neurophysiology/NN
,/,
and/CC
cancer/NN
[/(
7-10/CD
]/)
./.
====================
The/DT
molecular/JJ
understanding/NN
of/IN
ligand-receptor/NN
interactions/NNS
of/IN
GPCR/NN
remains/VBZ
unclear/JJ
and/CC
is/VBZ
still/RB
the/DT
subject/JJ
of/IN
investigations/NNS
./.
====================
There/EX
are/VBP
several/JJ
theories/NNS
explaining/VBG
the/DT
ligand-receptor/NN
interaction/NN
mechanism/NN
,/,
such/JJ
as/IN
shape/RB
theory/JJ
,/,
binding/VBG
theory/JJ
,/,
and/CC
vibration/NN
theory/JJ
[/(
11/CD
,/,
12/CD
]/)
./.
====================
The/DT
structures/NNS
of/IN
histamine/NN
receptor/NN
ligands/NNS
are/VBP
so/RB
variable/JJ
that/DT
we/PRP
can/MD
not/RB
easily/RB
classify/VB
the/DT
pharmacological/JJ
function/NN
of/IN
the/DT
ligand/NN
./.
====================
To/TO
find/VB
any/DT
other/JJ
characteristic/JJ
in/IN
the/DT
molecular/JJ
patterns/NNS
between/IN
agonists/NNS
and/CC
antagonists/NNS
of/IN
histamine/NN
receptors/NNS
,/,
a/DT
computational/JJ
approach/NN
to/TO
molecular/JJ
vibration/NN
was/VBD
carried/VBN
out/RP
in/IN
an/DT
attempt/NN
to/TO
find/VB
a/DT
bit/NN
of/IN
the/DT
molecular/JJ
interaction/NN
mechanisms/NNS
./.
====================
Dataset/NN
====================
The/DT
simplified/JJ
molecular-input/NN
line-entry/NN
system/NN
(/(
SMILES/NNS
)/)
and/CC
3-dimensional/JJ
structure/NN
data/NNS
format/VBP
(/(
SDF/NN
)/)
files/NNS
of/IN
the/DT
dataset/NN
were/VBD
downloaded/VBN
from/IN
the/DT
PubChem/JJ
Compound/NN
Database/NN
in/IN
National/JJ
Center/JJ
for/IN
Biotechnology/NN
Information/NN
(/(
NCBI/NN
)/)
and/CC
used/VBN
in/IN
the/DT
further/JJ
analyses/NNS
./.
====================
All/DT
47/CD
ligand/NN
molecules/NNS
in/IN
the/DT
dataset/NN
,/,
comprising/VBG
9/CD
histamine/NN
agonists/NNS
and/CC
38/CD
histamine/NN
antagonists/NNS
,/,
are/VBP
shown/VBN
in/IN
Table/JJ
1/CD
./.
====================
Structure/NN
comparison/NN
of/IN
histamine/NN
receptor/NN
ligands/NNS
====================
The/DT
molecular/JJ
similarities/NNS
between/IN
histamine/NN
and/CC
other/JJ
46/CD
chemicals/NNS
were/VBD
calculated/VBN
from/IN
SMILES/NNS
of/IN
the/DT
chemicals/NNS
./.
====================
The/DT
structural/JJ
similarity/NN
was/VBD
calculated/VBN
and/CC
represented/VBD
as/IN
the/DT
Tanimoto/NN
distance/NN
of/IN
each/DT
molecule/NN
from/IN
histamine/NN
./.
====================
The/DT
Tanimoto/NN
coefficient/JJ
for/IN
pairwise/JJ
comparison/NN
of/IN
molecules/NNS
is/VBZ
the/DT
most/JJS
widely/RB
used/VBN
measure/VB
of/IN
molecular/JJ
structural/JJ
similarity/NN
./.
====================
This/DT
coefficient/JJ
is/VBZ
defined/VBN
as/IN
Tc/JJ
=/JJ
Nab//JJ
(/(
Na/NN
+/CC
Nb/NN
-/:
Nab/NN
)/)
,/,
with/IN
Nab/NN
being/VBG
the/DT
number/NN
of/IN
common/JJ
bits/NNS
,/,
Na/NNP
the/DT
unique/JJ
bits/VBZ
in/IN
molecule/NN
a/DT
,/,
and/CC
Nb/NN
the/DT
unique/JJ
bits/VBZ
in/IN
molecule/NN
b/LS
,/,
using/VBG
a/DT
molecular/JJ
fingerprint/NN
[/(
13/CD
]/)
./.
====================
In/IN
this/DT
study/NN
,/,
the/DT
molecular/JJ
similarity/NN
was/VBD
calculated/VBN
as/IN
the/DT
Tanimoto/NN
coefficient/JJ
using/VBG
the/DT
38-bit/NN
set/NN
./.
====================
Geometry/NN
optimization/NN
and/CC
calculation/NN
of/IN
molecular/JJ
vibrational/JJ
frequency/NN
====================
In/IN
order/NN
to/TO
calculate/VB
molecular/JJ
vibrational/JJ
frequency/NN
,/,
the/DT
structure/NN
of/IN
a/DT
chemical/JJ
must/MD
first/JJ
be/VB
geometrically/RB
optimized/VBN
./.
====================
Since/IN
each/DT
provided/VBD
theoretical/JJ
3-D/NN
conformer/NN
SDF/NN
is/VBZ
not/RB
at/IN
an/DT
energy/NN
minimum/JJ
and/CC
may/MD
not/RB
represent/VB
the/DT
lowest/JJ
energetic/JJ
form/VBP
in/IN
a/DT
vacuum/NN
,/,
solvent/JJ
,/,
or/CC
a/DT
binding/VBG
pocket/NN
,/,
each/DT
SDF/NN
file/JJ
of/IN
a/DT
ligand/NN
molecule/NN
underwent/JJ
conversion/NN
to/TO
a/DT
single/JJ
low-energy/JJ
conformation/NN
using/VBG
the/DT
general/JJ
atomic/JJ
and/CC
molecular/JJ
electronic/JJ
structure/NN
system/NN
(/(
GAMESS/NN
)/)
program/NN
package/NN
[/(
14/CD
]/)
./.
====================
Restricted/VBN
Hartree-Fock/NN
(/(
RHF/NN
)/)
calculations/NNS
using/VBG
Becke/JJ
's/POS
exchange/NN
and/CC
Lee-Yang-Parr/JJ
's/POS
correlation/NN
functionals/VBZ
(/(
BLYP/NN
)/)
density/NN
functional/JJ
theory/JJ
(/(
DFT/NN
)/)
method/NN
with/IN
6-31G/JJ
basis/NN
set/NN
were/VBD
performed/VBN
to/TO
optimize/VB
the/DT
geometries/NNS
of/IN
the/DT
molecules/NNS
./.
====================
Each/DT
result/NN
was/VBD
taken/VBN
as/IN
the/DT
representative/JJ
conformation/NN
of/IN
the/DT
molecule/NN
,/,
although/IN
the/DT
calculation/NN
of/IN
molecular/JJ
vibrational/JJ
frequency/NN
has/VBZ
some/DT
dependence/NN
on/IN
conformation/NN
./.
====================
Each/DT
geometry/NN
optimization/NN
result/NN
was/VBD
subjected/VBN
to/TO
the/DT
calculation/NN
step/NN
for/IN
the/DT
vibrational/JJ
frequency/NN
with/IN
RUNTYP/NN
of/IN
HESSIAN/NN
in/IN
the/DT
GAMESS/NN
program/NN
./.
====================
Hierarchical/JJ
clustering/NN
of/IN
the/DT
corralled/JJ
intensity/NN
of/IN
molecular/JJ
vibrational/JJ
frequency/NN
(/(
CIMVF/NN
)/)
====================
For/IN
the/DT
simplified/JJ
molecular/JJ
comparison/NN
,/,
the/DT
calculated/JJ
vibrational/JJ
frequencies/NNS
of/IN
a/DT
molecule/NN
were/VBD
then/RB
sorted/VBN
in/IN
increasing/VBG
order/NN
and/CC
taken/VBN
into/IN
the/DT
corrals/NNS
,/,
the/DT
step/NN
size/NN
of/IN
which/WDT
was/VBD
5/CD
./.
====================
The/DT
intensities/NNS
of/IN
each/DT
frequency/NN
in/IN
the/DT
same/JJ
corral/JJ
were/VBD
summed/VBN
up/IN
as/IN
the/DT
representative/JJ
of/IN
the/DT
corral/JJ
in/IN
the/DT
frequency/NN
range/NN
of/IN
0-5,000/CD
cm-1/NN
./.
====================
As/IN
a/DT
final/JJ
outcome/NN
,/,
this/DT
potential/JJ
molecular/JJ
descriptor/NN
of/IN
each/DT
molecule/NN
was/VBD
displayed/VBN
in/IN
a/DT
1-dimensional/JJ
vector/NN
containing/VBG
1,000/CD
elements/NNS
./.
====================
Finally/RB
,/,
the/DT
similarity/NN
matrix/NN
,/,
comprising/VBG
the/DT
descriptors/NNS
of/IN
47/CD
ligands/NNS
of/IN
histamine/NN
receptor/NN
,/,
was/VBD
then/RB
subjected/VBD
to/TO
hierarchical/JJ
clustering/NN
in/IN
the/DT
agglomerative/JJ
manner/NN
./.
====================
In/IN
this/DT
study/NN
,/,
the/DT
similarity/NN
matrix/NN
was/VBD
finally/RB
clustered/VBN
to/TO
make/VB
an/DT
unrooted/JJ
tree/CD
of/IN
47/CD
vertices/NNS
./.
====================
The/DT
calculations/NNS
of/IN
CIMVF/NN
were/VBD
performed/VBN
by/IN
in-house/JJ
scripts/NNS
,/,
written/RB
in/IN
Python/NN
./.
====================
The/DT
Tanimoto/NN
coefficients/NNS
between/IN
histamine/NN
and/CC
other/JJ
ligand/NN
molecules/NNS
are/VBP
shown/VBN
in/IN
Table/JJ
2/CD
./.
====================
Typically/RB
,/,
a/DT
Tanimoto/JJ
coefficient/JJ
>/JJR
0.85/CD
is/VBZ
considered/VBN
highly/RB
similar/JJ
,/,
and/CC
a/DT
coefficient/JJ
>/JJR
0.75/CD
is/VBZ
considered/VBN
similar/JJ
for/IN
the/DT
purpose/NN
of/IN
clustering/NN
molecules/NNS
that/WDT
may/MD
have/VB
similar/JJ
biological/JJ
activity/NN
profiles/NNS
[/(
15/CD
]/)
./.
====================
The/DT
highest/JJS
Tanimoto/NN
coefficient/JJ
among/IN
agonists/NNS
was/VBD
0.45/CD
(/(
imetit/NN
)/)
,/,
and/CC
this/DT
is/VBZ
not/RB
high/JJ
enough/IN
to/TO
be/VB
considered/VBN
a/DT
molecule/NN
that/WDT
has/VBZ
potential/JJ
agonist/NN
efficacy/NN
./.
====================
Moreover/RB
,/,
the/DT
lowest/JJS
value/NN
of/IN
Tanimoto/NN
coefficient/JJ
among/IN
agonists/NNS
was/VBD
0.08/CD
(/(
dimaprit/NN
and/CC
SKF91488/NN
)/)
and/CC
is/VBZ
also/RB
a/DT
lower/JJR
value/NN
as/IN
an/DT
antagonist/NN
./.
====================
It/PRP
seems/VBZ
that/DT
there/EX
is/VBZ
no/DT
related/JJ
pattern/NN
between/IN
Tanimoto/NN
coefficients/NNS
and/CC
the/DT
functional/JJ
types/NNS
of/IN
molecules/NNS
in/IN
the/DT
case/NN
of/IN
histamine/NN
receptor/NN
agonists/NNS
or/CC
antagonists/NNS
./.
====================
To/TO
search/VB
for/IN
a/DT
novel/JJ
characteristic/JJ
for/IN
the/DT
classification/NN
of/IN
histamine/NN
receptor/NN
ligands/NNS
,/,
a/DT
kind/JJ
of/IN
molecular/JJ
calculation/NN
using/VBG
agglomerative/JJ
hierarchical/JJ
clustering/NN
was/VBD
adopted/VBN
in/IN
this/DT
work/NN
./.
====================
The/DT
result/NN
of/IN
the/DT
hierarchical/JJ
clustering/NN
of/IN
the/DT
similarity/NN
matrix/NN
from/IN
CIMVF/NN
is/VBZ
shown/VBN
in/IN
Fig/NN
./.
====================
2/CD
./.
====================
As/IN
shown/VBN
in/IN
the/DT
figure/NN
,/,
eight/CD
agonists/NNS
were/VBD
located/JJ
nearby/RB
(/(
the/DT
part/NN
in/IN
the/DT
dotted/JJ
circle/NN
)/)
,/,
except/IN
impromidine/NN
,/,
and/CC
all/DT
antagonists/NNS
were/VBD
clustered/VBN
close/JJ
to/TO
each/DT
other/JJ
in/IN
the/DT
radial/JJ
tree/CD
./.
====================
We/PRP
can/MD
tell/VB
the/DT
regional/JJ
difference/NN
between/IN
agonists/NNS
and/CC
antagonists/NNS
in/IN
the/DT
tree/JJ
and/CC
also/RB
find/VBP
that/IN
the/DT
information/NN
from/IN
the/DT
molecular/JJ
vibrational/JJ
frequency/NN
may/MD
play/VB
a/DT
role/NN
in/IN
the/DT
classification/NN
of/IN
agonists/antagonists/NNS
for/IN
histamine/NN
receptor/NN
as/IN
a/DT
possible/JJ
molecular/JJ
descriptor/NN
./.
====================
For/IN
these/DT
methods/NNS
,/,
clustering/NN
with/IN
CIMVF/NN
shows/VBZ
the/DT
more/RBR
proper/JJ
result/NN
in/IN
the/DT
case/NN
of/IN
histamine/NN
receptor/NN
ligands/NNS
./.
====================
With/IN
a/DT
more/RBR
concentrated/JJ
study/NN
on/IN
the/DT
relationship/NN
between/IN
the/DT
molecular/JJ
vibrational/JJ
frequency/NN
and/CC
pharmacological/JJ
function/NN
of/IN
a/DT
ligand/NN
,/,
the/DT
vibrational/JJ
spectrum/NN
of/IN
a/DT
molecule/NN
may/MD
shed/VB
light/NN
on/IN
the/DT
field/NN
of/IN
ligand-receptor/JJ
interaction/NN
mechanisms/NNS
./.
====================
The/DT
chemical/JJ
structure/NN
of/IN
histidine/NN
./.
====================
Radial/JJ
tree/CD
of/IN
corralled/JJ
intensity/NN
of/IN
molecular/JJ
vibrational/JJ
frequency/NN
(/(
CIMVF/NN
)/)
clustering/NN
using/VBG
the/DT
complete/JJ
linkage/NN
method/NN
./.
====================
Antagonists/NNS
are/VBP
tagged/VBN
with/IN
``/NN
t/NN
''/JJ
to/TO
their/PRP$
chemical/JJ
names/NNS
as/IN
a/DT
prefix/JJ
,/,
whereas/IN
agonists/NNS
are/VBP
not/RB
./.
====================
Agonists/NNS
of/IN
histamine/NN
receptors/NNS
except/IN
impromidine/NN
are/VBP
located/JJ
in/IN
a/DT
cluster/NN
(/(
the/DT
part/NN
in/IN
the/DT
dotted/JJ
circle/NN
)/)
./.
====================
List/NN
of/IN
agonists/NNS
and/CC
antagonists/NNS
used/VBN
in/IN
the/DT
present/JJ
study/NN
====================
The/DT
molecular/JJ
similarity/NN
between/IN
histamine/NN
and/CC
each/DT
ligand/NN
molecule/NN
in/IN
Tanimoto/NN
coefficient/JJ
====================
